Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

Fast-growing drugmaker Eli Lilly and Co. would consider Wisconsin sites for new plants beyond a $3 billion project the company announced ... those things matter more. As well as just the attitude ...

Eli Lilly is a big name in diabetes care and weight loss. Tirzepatide generates billions in revenue for the healthcare company ... it could be a matter of time before the Food and Drug ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other dividend stocks that beat the market in the last 3 years. The broader market has ...

Over the last two-plus years, as Eli Lilly and ... wondered which company’s products were more effective, there were constant reminders that there was no definitive answer until the compounds ...

Eli Lilly, the company that makes the blockbuster weight loss treatment Zepbound, will start studying its obesity products as treatments for alcohol and drug addiction, making it the first major ...

Enter Eli Lilly (NYSE ... consider that Lilly's market value is larger than Pfizer's, Moderna's, and J&J's combined! Moreover, Novo Nordisk is now the most valuable company in Europe -- ahead ...

Moreover, Novo Nordisk is now the most valuable company in Europe -- ahead of luxury fashion powerhouse LVMH Moët Hennessy. While it's clear that Lilly and Novo Nordisk are having a moment right ...